Presymtec’s decision-support technology uses proprietary predictive analytics to help COPD patients better manage their health by alerting them to developing infections up to 2 days before clinical symptoms. Using non-invasive, daily biometric readings, Presymtec's evidence-based alerts motivate behavior - like a "Check Engine" light - getting patients to the doctor earlier than symptoms would convince them to go. Since 70%-80% of COPD exacerbations are infection-induced, earlier intervention can improve outcomes and significantly reduce exacerbations, hospitalizations, and cost. The patient only needs to take two, non-invasive biometric readings each morning upon waking, i.e., waking temperature and waking peak flow (measurement of lung function), which are put into our website from any mobile device for an immediate report, all of which takes less than two minutes. This early awareness, especially valuable for chronic disease, infection-sensitive patients, such as those with COPD, ...
Presymtec’s decision-support technology uses proprietary predictive analytics to help COPD patients better manage their health by alerting them to developing infections up to 2 days before clinical symptoms. Using non-invasive, daily biometric readings, Presymtec's evidence-based alerts motivate behavior - like a "Check Engine" light - getting patients to the doctor earlier than symptoms would convince them to go. Since 70%-80% of COPD exacerbations are infection-induced, earlier intervention can improve outcomes and significantly reduce exacerbations, hospitalizations, and cost. The patient only needs to take two, non-invasive biometric readings each morning upon waking, i.e., waking temperature and waking peak flow (measurement of lung function), which are put into our website from any mobile device for an immediate report, all of which takes less than two minutes. This early awareness, especially valuable for chronic disease, infection-sensitive patients, such as those with COPD, our initial target population, as well as cancer, CHF, CF, HIV/AIDS, etc., is sooner than ever before and helps the patient better manage their health and know “when” to go to the doctor for an early evaluation / treatment. Presymtec’s early warning system is available now as an Internet SaaS service, which can scale to serve virtually any number of users in nearly any region. It’s confidential, HIPAA-compliant, and simple to use by anyone with ordinary skills. It allows daily measurement input and immediate reporting on an easy-to-read three column, color-coded bar chart that displays, in five levels of sensitivity, the likelihood of an infection, a respiratory condition, and/or a respiratory infection, while distinguishing among them. It also records patient data on a proprietary scaled graph that permits trending analysis, displays characteristic graph signatures of health-state changes, and permits immediate email / text alerts to care professionals for prompt follow-up to enable even faster medical intervention. In 2016, Presymtec’s patented, hand-held Monitor, which is a novel combination of a digital thermometer and peak flow meter, is scheduled for completion and it will facilitate patient data acquisition, has immediate patient reporting on an on-board display, and permits wireless transmission of daily readings to the Company’s servers for tracking, graph reporting, and alert notices to care professionals and family.
More information